The SEAB is a consultative body which is formed to ensure and improve the scientific performance and the quality of results of CAM-PaC. The members of the SEAB will be invited to the annual GA meetings in order to monitor the progress of work, to assess the scientific quality and to give feed-back to the Consortium members, but without a right to vote. The SEAB will also consider and mention any ethical issues which might require (stronger) attention in their feed-back.
Six renowned experts from the relevant scientific fields of CAM-PaC have agreed to be part of the CAM-PaC Scientific and Ethical Advisory Board:
- Dr. Thomas Joos, Head of Biochemistry, NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany (diagnostic assays for gene signatures and assays for use in industry)
- Prof.Dr. David Tuveson MD, PhD; Professor and Deputy Director of Cancer Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (GEMM, the group of D.Tuveson developed the most relevant PDAC-GEMM)
- Prof.Dr. Thomas Herget, Head of Processing Technologies, Merck Millipore Division – Process Solutions, Darmstadt, Germany (assays, tools and tests for pharmaceutical industry)
- Dr. Anette Sommer, Global Drug Discovery - TRG Oncology, Bayer Pharma AG, Berlin, Germany (selection of candidate genes as drug targets)
- Prof.Dr. Rudi Balling, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg (expert in systems biology and fluxomics)
- Prof.Dr. Gerd Richter, Ethics Commission of the Faculty of Medicine, Philipps Universitaet Marburg, Marburg, Germany (Ethical Advisor)